In melanoma cells, B-Raf is responsible for much of the signaling of the MAPK/ERK signaling pathway, and inhibition of B-Raf is compensated for by c-Raf activation and downstream MEK and ERK [21, 30]. Here, BRAF is linked to melanoma.